Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 18 F-AV-1451 binds to putamen in multiple system atrophy.

Literature DB >> 27859717

¹⁸ F-AV-1451 binds to putamen in multiple system atrophy.

Hanna Cho¹, Jae Yong Choi², Seung Ha Lee¹, Young Hoon Ryu², Myung Sik Lee¹, Chul Hyoung Lyoo¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2016 PMID： 27859717 DOI： 10.1002/mds.26857

Source DB: PubMed Journal: Mov Disord ISSN： 0885-3185 Impact factor: 10.338

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.

Authors: Shunsuke Koga; Maiko Ono; Naruhiko Sahara; Makoto Higuchi; Dennis W Dickson
Journal: Mov Disord Date: 2017-04-25 Impact factor: 10.338

2. MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([¹⁸F]-AV-1451) Binding.

Authors: Allan K Hansen; David J Brooks; Per Borghammer
Journal: Mol Imaging Biol Date: 2018-06 Impact factor: 3.488

Review 3. Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms.

Authors: Cecilia Peralta; Antonio P Strafella; Thilo van Eimeren; Roberto Ceravolo; Klaus Seppi; Valtteri Kaasinen; Julieta E Arena; Stephane Lehericy
Journal: Mov Disord Clin Pract Date: 2021-11-15

Review 4. The Role of Tau Imaging in Parkinsonian Disorders.

Authors: Jochen Hammes; Alexander Drzezga; Thilo van Eimeren
Journal: Curr Neurol Neurosci Rep Date: 2018-10-06 Impact factor: 5.081

5. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.

Authors: Marta Marquié; Eline E Verwer; Avery C Meltzer; Sally Ji Who Kim; Cinthya Agüero; Jose Gonzalez; Sara J Makaretz; Michael Siao Tick Chong; Prianca Ramanan; Ana C Amaral; Marc D Normandin; Charles R Vanderburg; Stephen N Gomperts; Keith A Johnson; Matthew P Frosch; Teresa Gómez-Isla
Journal: Acta Neuropathol Commun Date: 2017-10-19 Impact factor: 7.801

Review 10. PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape.

Authors: Bright Chukwunwike Uzuegbunam; Damiano Librizzi; Behrooz Hooshyar Yousefi
Journal: Molecules Date: 2020-02-21 Impact factor: 4.411

10 in total

¹⁸ F-AV-1451 binds to putamen in multiple system atrophy.

1. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.

2. MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([¹⁸F]-AV-1451) Binding.

Review 3. Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms.

Review 4. The Role of Tau Imaging in Parkinsonian Disorders.

5. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.

Review 6. Tau PET imaging in neurodegenerative tauopathies-still a challenge.

7. Tau Imaging in Parkinsonism: What Have We Learned So Far?

Review 8. Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.

Review 9. Imaging Protein Misfolding in the Brain Using β-Sheet Ligands.

Review 10. PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape.

18 F-AV-1451 binds to putamen in multiple system atrophy.

1. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.

2. MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding.

Review 3. Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms.

Review 4. The Role of Tau Imaging in Parkinsonian Disorders.

5. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.

Review 6. Tau PET imaging in neurodegenerative tauopathies-still a challenge.

7. Tau Imaging in Parkinsonism: What Have We Learned So Far?

Review 8. Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.

Review 9. Imaging Protein Misfolding in the Brain Using β-Sheet Ligands.

Review 10. PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape.

¹⁸ F-AV-1451 binds to putamen in multiple system atrophy.

2. MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([¹⁸F]-AV-1451) Binding.